Annals of Hematology

Article	Citations
Refractory hepatosplenic T-cell lymphoma was successfully treated with salvage allogeneic hematopoietic stem cell transplantation combined with enhanced myeloablative preconditioning	75
A case of acute promyelocytic leukemia with pericardial effusion successfully managed with colchicine during ATO administration	53
Correction to: Hemophagocytic lymphohistiocytosis in HIV-associated lymphoproliferative disorders	51
Concomitant multiple sclerosis and polycythemia vera successfully treated with glatiramer acetate	51
Clonal evolution analysis of a rare acute promyelocytic leukemia patient transforming from essential thrombocythemia	49
Impact of race and ethnicity on outcomes after autologous stem cell transplantation for patients with newly diagnosed multiple myeloma	49
CAG (cytarabine, aclarubicin and granulocyte colony-stimulating factor) regimen for core binding factor acute myeloid leukaemia with measurable residual disease	49
Efficacy and safety of olverembatinib as maintenance therapy after allogeneic hematopoietic cell transplantation in Philadelphia chromosome–positive acute lymphoblastic leukemia	49
Refractory pure red cell aplasia associated with T-cell large granular lymphocyte leukemia treated by ruxolitinib	43
T-cell acute lymphoblastic leukemia: therapeutic outcomes in adolescents and young adults	36
“In situ” MYC rearrangement and amplification as a secondary change in a case of High-grade B cell lymphoma with 11q aberration	35
Stem cell mobilization in multiple myeloma: challenges, strategies, and current developments	34
Coefficient of variation and texture analysis of 18F-FDG PET/CT images for the prediction of outcome in patients with multiple myeloma	32
Radiotherapy alone with curative intent in a case of limited-stage extranodal NK/T-cell lymphoma nasal type: a case report and review of the literature	31
Real-life use of mTOR inhibitor-based therapy in adults with autoimmune cytopenia highlights strong efficacy in relapsing/refractory multi-lineage autoimmune cytopenia	29
Absence of blood donors’ anti-SARS-CoV-2 antibodies in pre-storage leukoreduced red blood cell units indicates no role of passive immunity for blood recipients	28
Advances in the ocular complications after hematopoietic stem cell transplantation	28
Predictive factors of romiplostim response in patients with refractory aplastic anemia: data from two clinical trials	26
Outcome of patients with diffuse large B-cell lymphoma and testicular involvement – real world data	24
Prognostic impact of TET2 mutations in patients with acute myeloid leukemia: HM-SCREEN-Japan 01 and 02 study	23
Safe administration of venetoclax-obinutuzumab in a chronic lymphocytic leukemia patient with Brugada syndrome	23
Second allogeneic transplantation in relapsed acute leukemia – a risk worth taking?	23
Germline mutations predispose a concurrent thymoma and diffuse large B-cell lymphoma	23
Optimizing hemophagocytic lymphohistiocytosis screening in children: validation of the HLH-Screen score	23
Leukemia cutis in accelerated chronic lymphocytic leukemia: successful treatment with venetoclax and rituximab	22

Whole-exome sequencing identifies FANC heterozygous germline mutation as an adverse factor for immunosuppressive therapy in Chinese aplastic anemia patients aged 40 or younger: a single-center retrosp	22
Renin-angiotensin inhibitors reduce thrombotic complications in Essential Thrombocythemia and Polycythemia Vera patients with arterial hypertension	22
A randomized controlled trial of thrice-weekly versus thrice-daily oral ferrous fumarate treatment in adult patients with iron-deficiency anemia	22
Trimethoprim-sulfamethoxazole prevents interstitial pneumonitis in B-cell lymphoma patients receiving chemotherapy: a propensity score matching analysis	20
Prognostic significance of in patients with chronic lymphocytic leukemia: A meta-analysis	19
Causes of death and treatment-related mortality in newly diagnosed childhood acute lymphoblastic leukemia treatment with Chinese Children’s Cancer Group study ALL-2015	19
Treatment patterns and healthcare resource utilization in ruxolitinib-treated patients with myelofibrosis with and without anemia: a real-world analysis	18
Intramural esophageal hematoma precipitated by acquired factor XI deficiency in a patient with relapsed T cell prolymphocytic leukemia after allogeneic hematopoietic cell transplantation	18
Correction to: Delphi consensus recommendations on treatment for advanced-stage marginal zone lymphoma in South Korea	18
Molecular profiling of cell-free DNA from classic Hodgkin lymphoma patients identifies potential prognostic clusters and corresponds with disease dynamics	17
Incidence of pneumonia among bruton tyrosine kinase inhibitors in chronic lymphocytic leukemia: a systematic review and meta-analysis of clinical trials	17
Copy number alterations in pediatric B-cell precursor acute lymphoblastic leukemia patients and their association with patients’ outcome	17
Symposium Proceedings of the international symposium ACUTE LEUKEMIAS XIX (ISALXIX), Munich March 16–19, 2025	17
Activity of trametinib as maintenance therapy after allogeneic hematopoietic stem cell transplantation in patients with relapsed or refractory RAS pathway-mutated hematologic malignancies	16
Paroxysmal nocturnal haemoglobinuria in pregnancy–a systematic review with meta analysis	16
Genetic variability profiling of the p53 signaling pathway in chronic lymphocytic leukemia. Individual and combined analysis of TP53, MDM2 and NQO1 gene variants	16
Overview of 1q abnormalities in multiple myeloma: scientific opinions from Italian experts	16
Clinical profile and treatment outcomes in paediatric and adult acute promyelocytic leukemia: experience from a tertiary care centre in Northern India	15
Basophilia and eosinophilia in polycythemia vera and essential thrombocythemia: clinical, genotype, and prognostic correlates	15
Hospital facility characteristics and socioeconomic factors on outcomes and treatment in patients with multiple myeloma: National Cancer Database analysis	15
Outcomes by best response with hypomethylating agent plus venetoclax in adults with previously untreated acute myeloid leukemia	15
Circulating tumor DNA assisting lymphoma genetic feature profiling and identification	15
A nomogram model for predicting the efficacy of cyclosporine in patients with pure red cell aplasia	15
CML in the very elderly: the impact of comorbidities and TKI selection in a real-life multicenter study	15
Risk factors and outcome of Stenotrophomonas maltophilia infection after allogeneic hematopoietic stem cell transplantation: JSTCT, Transplant Complications Working Group	15
Impact of induction regimens on stem cell mobilization yields in newly diagnosed multiple myeloma	15
Sufficient vitamin D is favorable for children with persistent and chronic immune thrombocytopenia	14
Health-related quality of life with daratumumab, bortezomib, melphalan, and prednisone versus bortezomib, melphalan, and prednisone alone in transplant-ineligible patients with newly diagnosed multipl	14
Effectiveness of prophylactic antiviral therapy in reducing HBV reactivation for HBsAg-positive recipients following allogeneic hematopoietic stem cell transplantation: a multi-institutional experienc	14
Nomogram for predicting survival of patients with diffuse large B-cell lymphoma	14
Refractory primary immune thrombocytopenia (ITP): current clinical challenges and therapeutic perspectives	14
Global, regional and national temporal trends in incidence and mortality of non-Hodgkin lymphoma from 1992 to 2021: an age-period-cohort analysis	14
Ferroptosis: a new target for iron overload-induced hemophilic arthropathy synovitis	14
Maternal factors associated with iron deficiency without anaemia in early pregnancy: ECLIPSES study	14
Licochalcone A decreases cancer cell proliferation and enhances ferroptosis in acute myeloid leukemia through suppressing the IGF2BP3/MDM2 cascade	13
Reporting of adverse events of treatment interventions in multiple myeloma: an overview of systematic reviews	13
Molecular response with asciminib 20 mg QD in a patient intolerant to multiple TKIs	13
Cerebral infarction in a patient with inhibitor-positive hemophilia B treated with plasma-derived factor VIIa and factor X mixture	13
Post-transplant lymphoproliferative disease of two different histological types	13
A novel WNK1::PDGFRB fusion gene in myeloid neoplasm with eosinophilia: a case report	13
Clinical value of ALK and CD30 expression in mature systemic T cell lymphomas: analysis from the Czech Lymphoma Study Group database (NIHIL)	13
Advances in epigenetic therapies for B-cell non-hodgkin lymphoma	13
Bilateral deafness in NK/T-cell lymphoma: EBV DNA prevailed over magnetic resonance imaging	13
Achievement of rapid complete remission in an 87-year-old female patient with azacytidine-venetoclax for blastic plasmacytoid dendritic cell neoplasm	13
Treatment patterns and outcomes for Hodgkin Lymphoma patients aged 60 and older: a report from the Brazilian Prospective Hodgkin Lymphoma Registry	13
Specificity protein 1/3 regulate T-cell acute lymphoblastic leukemia cell proliferation and apoptosis through β-catenin by acting as targets of miR-495-3p	13
Comprehensive comparison of international prognostic indexes for follicular helper T-cell lymphoma	12
A cohort of allogeneic hematopoietic stem cell transplantation for pediatric rare diseases (allo-HSCT-PRD): design and preliminary results	12
The first successful expanded compassionate use of Iptacopan in a patient with paroxysmal nocturnal hemoglobinuria	12
CD20/CD79a/PAX5/CD3-negative post-transplant lymphoma with aberrant actin and desmin co-expression—a potential differential diagnostic pitfall between PTLD and PTSMT	12

Identification of CD105 (endoglin) as novel risk marker in CLL	12
Management of latent tuberculosis infection (LTBI) in adult patients with newly diagnosed acute leukemia: results of a survey among Italian centers belonging to SEIFEM (Sorveglianza Epidemiologica Inf	12
Real-world study on patient characteristics, treatment patterns and outcomes for treated patients with chronic lymphocytic leukemia during 2013–2022 in Finland	12
Correction to: Potential risk factors for the development from immune thrombocytopenia to systemic lupus erythematosus: a case–control study in Chinese children	12
Midostaurin added to 10-day decitabine, for patients unfit for intensive chemotherapy with AML and higher risk MDS, irrespective of FLT3 mutational status, does not improve outcome	12
A multicentre ambispective observational study into the incidence and clinical management of aplastic anaemia in Spain (IMAS study)	12
TRAF3IP3::FGFR1: a novel FGFR1 fusion identified in an aggressive case of acute myeloid leukemia	12
Efficacy and safety analysis of different treatment regimens in newly diagnosed acute promyelocytic leukemia	12
Correction to: Spanish registry of hemoglobinopathies and rare anemias (REHem- AR): demographics, complications, and management of patients with β-thalassemia	12
Low-dose venetoclax combined with azacitidine for blastic plasmacytoid dendritic cell neoplasm: a case report and literature review	12
Radiation hazards of the Ukraine nuclear power plants: how can international blood and marrow stem cell transplant societies help?	11
Altered serum lipid levels are associated with prognosis of diffuse large B cell lymphoma and influenced by utility of rituximab	11
Critical risk factors analysis of infection-associated hemophagocytic lymphohistiocytosis in children	11
Immune profiling of patients with extranodal natural killer/T cell lymphoma treated with daratumumab	11
PNH clones prevalence study in ph-negative myeloproliferative neoplasms: a multicenter Italian study	11
Impact of the presence and number of chromosomal abnormalities on the clinical outcome in Waldenström Macroglobulinemia: a monocentric experience	11
TGFBI regulates the TGF-β pathway to affect the malignant progression and cisplatin sensitivity in diffuse large B-cell lymphoma	11
Matching-adjusted indirect comparison of CPX- 351 in secondary Acute Myeloid Leukemia between the registrative trial and a real-life study	11
Mutational heterogeneity in large B-cell lymphoma: insights from paired biopsies	11
Clinical features and outcomes of 17 children with systemic juvenile xanthogranuloma (sJXG) including five complicated with hemophagocytic lymphohistiocytosis (HLH)	11
Successful rechallenge with azacytidine and venetoclax after sustained treatment-free remission in a relapsed acute myeloid leukemia patient: a case report	11
Safety and efficacy of daratumumab in Chinese patients with relapsed or refractory multiple myeloma: a phase 1, dose-escalation study (MMY1003)	11
Ropeginterferon phase 2 randomized study in low-risk polycythemia vera: 5-year drug survival and efficacy outcomes	11
Autologous stem cell transplantation with thiotepa, busulfan, and cyclophosphamide conditioning in patients with central nervous system lymphoma: a phase II study	10
Adipocyte fatty acid-binding protein (FABP4) as a potential biomarker for predicting metabolically driven low-grade and organ damage in thalassemia syndromes	10
Optimal dosage of rituximab for children with Burkitt lymphoma	10
COVID-19: impact of vaccination in myeloma patients	10
Multiplex digital PCR enables sensitive detection of resistance to BTK inhibitors	10
Safety of romiplostim administered immediately after cord-blood transplantation: a phase 1 trial	10
Zebrafish modeling of atypical PML-RARA isoform from acute promyelocytic leukemia patient and its implications for clinical treatment	10
Feasibility of allogeneic stem cell transplantation (HSCT) in patients with acute myeloid leukemia previously treated with CPX-351: report from a single center	10
Severe platelet transfusion refractoriness due to anti-HPA-5a antibody during induction chemotherapy for acute promyelocytic leukemia	10
Sex differences in fatigue and symptoms of anemia in relation to hemoglobin level in hospitalized patients	10
Efficacy and safety of new-generation Bruton tyrosine kinase inhibitors in chronic lymphocytic leukemia/small lymphocytic lymphoma: a systematic review and meta-analysis	10
Acute liver failure associated with human adenovirus infection after allogeneic hematopoietic stem cell transplantation	10
Chronic neutrophilic leukemia with JAK2 mutation: is it true chronic neutrophilic leukemia?	10
Re-induction therapy in patients with acute myeloid leukemia not in complete remission after the first course of treatment	10
Donor’s age influences outcome in haploidentical hematopoietic stem cell transplantation with post-transplant cyclophosphamide - a single center experience	10
A comparative study of platelet storage lesion in platelet-rich plasma under cryopreservation	10
Practical considerations in the management of patients treated with bosutinib for chronic myeloid leukemia	10
Management of paroxysmal nocturnal hemoglobinuria with low-level hemolysis in pregnancy– a report of two cases	10
Efficacy and safety of allogeneic hematopoietic cell transplantation in acute myeloid leukemia patients aged > 65 years with unfavorable cytogenetics	10
Clinical significance of C-reactive protein/platelet ratio from diagnosis to allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia	10
Daratumumab plus bortezomib or daratumumab plus lenalidomide as salvage therapy for patients with myeloma: initial follow-up of an Italian multicentre retrospective clinical experience by ‘Rete Ematol	10
Are accessory spleen screening and resection in refractory immune cytopenia an effective strategy or a waste of resources?	10
No aggravation of congenital thrombotic thrombocytopenic purpura by mRNA-based vaccines against COVID-19: a Japanese registry survey	10
A new score for predicting intracranial hemorrhage in patients using antiplatelet drugs	10
Adult type I Gaucher disease with splenectomy caused by a compound heterozygous GBA1 mutation in a Chinese patient: a case report	10
Sickle cell disease and opioid overdose outcomes in the United States: a nationwide analysis	10
Bisphosphonate use for glucocorticoid-induced osteoporosis in older patients with immune thrombocytopenia: a clinical perspective	10
Overcoming right heart failure through successful treatment of cardiac dominant diffuse large B-cell lymphoma: a case report	9
Is comprehensive geriatric testing guiding in the identification of multiple myeloma patients who are candidates for autologous stem cell transplantation? A prospective analysis	9
Bibliometric analysis of worldwide research on Polycythemia Vera in the 21st century	9
Identification of a novel cryptic variant chromosomal rearrangement involving 9q34, 22q11.2, and 5q22 resulting in ins(9;22) and t(5;22) in chronic myeloid leukemia: a case report	9
Impact of letermovir prophylaxis in CMV reactivation and disease after allogenic hematopoietic cell transplantation: a real-world, observational study	9
Prognostic factors and effect modifiers in patients with relapsed or refractory follicular lymphoma who failed at least two lines of therapy: a systematic literature and expert clinical review	9
Pseudothrombocytopenia, beyond a laboratory phenomenon: study of 192 cases	9
Characteristics and outcomes of COVID-19 in patients with plasma cell dyscrasias during the first Omicron wave in Beijing since December 2022: a retrospective study at a National Clinical Research Cen	9
In-depth molecular analysis of lymphomas with lymphoplasmacytic differentiation may provide more precise diagnosis and rational treatment allocation	9
A case of JAK2 V617F positive essential thrombocythemia successfully controlled by imatinib mesylate	9
Validity of the criteria for clinical transformation of follicular lymphoma: analysis of a mostly biopsied cohort	9
Benefit of high-dose idarubicin as induction therapy in acute myeloid leukemia: a prospective phase 2 study	9
Tandem autologous hematopoietic stem cell transplantation in multiple myeloma: A historical perspective and current challenges	9
Comparison of prognostication by IPSS-M, IPSS-R and AIPSS-MDS in the context of limited availability of molecular data in daily clinical practice	9
Low incidence of severe acute and chronic graft-versus-host disease in a long-term retrospective study with ATG Grafalon routine use	9
Incidence, risk factors, and outcomes of second neoplasms in patients with acute promyelocytic leukemia: the PETHEMA-PALG experience	9
Immune reconstitution and survival of patients with parvovirus B19 related pure red cell aplasia after haplo-PBSCT	9
Interim PET in follicular lymphoma: more patience, please	9
2-[18]F FDG PET/CT dissemination features in adult burkitt lymphoma Are predictive of outcome	9
Hepatic, gastric and bone marrow AL amyloidosis that began with Budd-Chiari syndrome: a case report	9
Prognostic value of laboratory biomarkers for mortality risk stratification in thrombotic thrombocytopenic purpura	9
Analytical considerations affecting plasma free haemoglobin, the haemolysis index, and correlation with clinical outcomes in sickle cell disease	9
Efficacy and safety of generic pomalidomide plus low-dose dexamethasone in relapsed or refractory multiple myeloma: a multicenter, open-label, single-arm trial	9
Association between low incidence of TP53 mutations and reduced early relapse rates in Uygur DLBCL	8
Mendelian randomization of circulating proteome identifies IFN-γ as a druggable target in aplastic anemia	8
Analysis of Wilms’ tumor protein 1 specific TCR repertoire in AML patients uncovers higher diversity in patients in remission than in relapsed	8
Initial management of patients with acquired aplastic anemia in the United States: results from a large national claims database	8
Treatment of refractory or relapsed myelodysplastic neoplasms with luspatercept: a multicenter Chinese study	8
Validation of the simplified geriatric prognostic index in a Hellenic database of older patients (≥ 70 years old) with diffuse large B-cell lymphoma and similar disorders	8
Impact of baseline and interim quantitative PET parameters on outcomes of classical Hodgkin Lymphoma	8

A promising natural product in diffuse large B-cell lymphoma therapy by targeting PIM1	8
Evaluation of the cachexia index using a bioelectrical impedance analysis in elderly patients with non-Hodgkin’s lymphoma: A single-center prospective study	8
Development of disseminated intravascular coagulation in asymptomatic leukemic non-nodal mantle cell lymphoma	8
A real-world analysis of PD1 blockade from the Rete Ematologica Pugliese (REP) in patients with relapse/refractory Hodgkin’s lymphoma	8
Clinical features and outcomes in large granular lymphocyte leukemia − associated pure red cell aplasia with STAT3 mutation	8
Platelet recovery with ibrutinib therapy in patient with treatment-refractory immune thrombocytopenia	8
Analysis of PROS1 mutations and clinical characteristics in three Chinese families with hereditary protein S deficiency	8
The experience of diagnosis and treatment for TAFRO syndrome	8
Incidence and reasons for discontinuation of first-line therapy in patients with multiple myeloma: results from a historical cohort, Brazil 2009–2020	8
Relationship between subtype-specific minimal residual disease level and long-term prognosis in children with acute lymphoblastic leukemia	8
The roles of ubiquitination in AML	8
Post-transplant transient abnormal myelopoiesis evolving from a GATA1 mutant clone in umbilical cord blood	8
Bone marrow involvement is a risk factor for infusion-related reactions in patients with follicular lymphoma treated by obinutuzumab	8
Immunophenotypic profile defines cytogenetic stability and unveils distinct prognoses in patients with newly-diagnosed multiple myeloma (NDMM)	8
Development and validation of nomogram prognostic model for predicting OS in patients with diffuse large B-cell lymphoma: a cohort study in China	8
Epigenetically dysregulated NOTCH-Delta-HES signaling cascade can serve as a subtype classifier for acute lymphoblastic leukemia	8
Prognostic factors for patients with hematologic malignancies admitted to the intensive care unit: is allogeneic transplantation still a risk factor?	8
An unexpected find of multifocal extranodal marginal zone lymphoma	8
Functional apoptosis profiling reveals vulnerabilities in T-cell large granular lymphocytic leukemia	8
Association between N-acetylcysteine treatment and in-hospital mortality in adult patients with acquired thrombotic thrombocytopenic purpura: a cohort study	8
ALPS, FAS, and beyond: from inborn errors of immunity to acquired immunodeficiencies	8
Efficacy of venetoclax combined with decitabine conditioning regimen for allogeneic hematopoietic stem cell transplantation in high-risk and elderly patients with myeloid neoplasms	8
Clinical prognostic value of different NPM1 mutations in acute myeloid leukemia patients	8
Prognostic significance of early nk cell recovery in pediatric t-cell replete allogeneic hematopoietic stem cell transplantation	8
Patient-reported outcome domains in multiple myeloma randomized controlled trials and association with survival outcomes	8
Venetoclax in combination with FLAG-IDA-based protocol for patients with acute myeloid leukemia: a real-world analysis	8
A synchronous therapy with daratumumab and enzymatic replacement therapy (ERT) in a patient with Gaucher disease and multiple myeloma	8
Characteristics of inpatients with newly diagnosed multiple myeloma in hematology, nephrology, and orthopedic departments	8
VEXAS syndrome: is it more a matter of inflammation or hematopoietic clonality? A case series approach to diagnosis, therapeutic strategies and transplant management	8
Challenges in accuracy in molecular genetic diagnosis of childhood AML: case series	8
Estimating prognostic relevant cutoff values for a multiplex PCR detecting BCR::ABL1 in chronic myeloid leukemia patients on tyrosine kinase inhibitor therapy in resource-limited settings	8
Real-world challenges in the management of acute myeloid leukemia: a single-center experience from North India	8
Romiplostim versus Recombinant human thrombopoietin in umbilical cord blood transplantation: a single-center retrospective study	8
Cord blood resilience in a patient with relapsing Ph + B lymphoblastic acute leukemia after hematopoietic stem cell transplantation	8
Sequential eradication of Helicobacter pylori as a treatment for immune thrombocytopenia in patients with moderate thrombocytopenia: a multicenter prospective randomized phase 3 study	7
Correction to: One disease, two faces: clonally-related AML and MPDCP with skin involvement	7
Acquired Gray platelet syndrome as a rare hematologic complication in a case of JAK2-positive post polycythemia Vera myelofibrosis	7
Mass cytometry analysis identifies T cell immune signature of aplastic anemia and predicts the response to cyclosporine	7
miR-603 promotes cell proliferation and differentiation by targeting TrkB in acute promyelocytic leukemia	7
Safe utilization of ruxolitinib in simultaneous primary myelofibrosis and warm autoimmune hemolytic anemia	7
Co-occurrence of Erdheim-Chester disease and clonally evolving acute myeloid leukemia with FLT3-ITD and PTPN11 mutations	7
A case of visual impairment due to HHV-6 encephalitis after allogeneic hematopoietic stem cell transplantation in childhood acute myeloid leukemia-M2 subtype	7
Prognostic value of metabolic tumor volume of extranodal involvement in diffuse large B cell lymphoma	7
Sickle cell disease and acute leukemia: one case report and an extensive review	7
Enhancing outcomes of childhood acute lymphoblastic leukemia in workplace diversity in Thailand: multicenter study on behalf of the Thai Pediatric Oncology Group	7
Real-world therapeutic response and tyrosine kinase inhibitor discontinuation in chronic phase-chronic myeloid leukemia: data from the French observatory	7
Efficacy and safety analysis of China’s first 10% IVIg (RonsenGlob) therapy in treating adult ITP	7
Impact of protein-energy malnutrition on outcomes of patients with sickle cell disease: an analysis of the National inpatient sample	7
Oncology stewardship in acute myeloid leukemia	7
A predictive diagnostic model for refractory diffuse large B-cell lymphoma: a single-center retrospective cohort study	7
Development and validation of an early mortality risk model for pediatric hemophagocytic lymphohistiocytosis: a comparison with HScore, PELOD-2, P-MODS, and pSOFA	7
L-DEP regimen is effective as an initial therapy for adult EBV-HLH	7
Impact of gemtuzumab ozogamicin consolidation on hematopoietic stem cells (HSCs) mobilization in AML: analysis of 20 patients	7
Prognostic factors in patients with secondary hemophagocytic lymphohistioc ytosis in a Chinese cohort	7
Alectinib maintenance therapy following cord blood transplantation for relapsed pediatric anaplastic large cell lymphoma with central nervous system involvement	7
Two cases of refractory IgG4-related disease successfully treated with tocilizumab	7
Monocyte-to-platelets ratio (MPR) at diagnosis is associated with inferior progression-free survival in patients with mantle cell lymphoma: a multi-center real-life survey	7
How to combine multiple tools for the genetic diagnosis work-up of pediatric B-cell acute lymphoblastic leukemia	7
A case report of dyskeratosis congenita caused by a novel TERC mutation	7
Anticoagulation strategies and recurrence of venous thromboembolic events in patients with sickle cell disease: a systematic review and meta-analysis	7
Broadening perspectives: redefining the role of obesity in ITP	7
Enhanced efficacy of combined fluzoparib and chidamide targeting in natural killer/T-cell lymphoma	7
Autotaxin is a potential predictive marker for the development of veno-occlusive disease/sinusoidal obstruction syndrome after allogeneic hematopoietic cell transplantation	7
Construction of AML prognostic model with CYP2E1 and GALNT12 biomarkers based on golgi- associated genes	7
Perspectives and challenges of small molecule inhibitor therapy for FLT3-mutated acute myeloid leukemia	7
Outcomes of the transformation to diffuse large B-cell lymphoma in hodgkin lymphoma and indolent B-cell non-Hodgkin lymphoma: a population-based study	7
Polatuzumab Vedotin, zanubrutinib and rituximab (Pola-ZR) achieved rapid and deep response in untreated frail and elderly DLBCL	7
Investigation of TSRP reverses imatinib resistance through the PI3K / Akt pathway in chronic myeloid leukemia	7
Early predictor for differentiation syndrome in newly diagnosed acute promyelocytic leukaemia patients treated with single-agent arsenic trioxide	7
Association between HLA-DRB1*04, HLA-DQB1*03, and HLA-DQB1*06 with alloimmunization in transfusion-dependent patients with thalassemia: the first case-control study in Iran	7
Prognostic significance of angiogenesis-associated molecules and Immunologic characteristic in elderly patients with acute myeloid leukemia	7
Clinical features and fusion gene analysis of two Torque Teno Mini virus associated acute promyelocytic leukemia cases	7
Real-world outcomes and prognostic factors in primary mediastinal B-cell lymphoma: a multicenter study of 157 patients	7
Intestinal microbiota score could predict survival following allogeneic hematopoietic stem cell transplantation	7
Magnitude of cumulative iron overload correlates with the severity of anemia in untreated non-transfusion-dependent β-thalassemia	7
Comparable clinical outcomes of haploidentical hematopoietic stem cell transplantation in patients with hepatitis-associated aplastic anemia and non-hepatitis-associated aplastic anemia	7
An inherited genetic variant of the CEP72 gene is associated with the development of vincristine-induced peripheral neuropathy in female patients with aggressive B-cell lymphoma	7
Benefit of consolidative radiation in patients with extranodal limited-stage diffuse large B-cell lymphoma: a multicenter retrospective study in China	7
Case report:Clinical manifestations and therapeutic options following rhTPO-induced neutralizing antibody production in a child with immune thrombocytopenia	7
Rhabdomyolysis induced by nelarabine	7
Validation of a Stenotrophomonas maltophilia bloodstream infection prediction score in the hematologic malignancy population	7
Hemolytic anemia in COVID-19	7
Molecular characteristics of hereditary red blood cell membrane disorders in Thailand: a multi-center registry	7
Clinical efficacy and tolerability of venetoclax plus rituximab in patients with relapsed or refractory chronic lymphocytic leukemia—a real-world analysis of the Polish Adult Leukemia Study Group	7
N-Acetylcistein for thrombotic thrombocytopenic purpura: an observational case series study	7
Autologous hematopoietic stem cell transplantation improves survival outcomes in peripheral T-cell lymphomas: a multicenter retrospective real-world study	7
Blinatumomab-induced macrophage activating syndrome (MAS) in adult with B-cell acute lymphoblastic leukemia (B-ALL)	7
The effects of complement-independent, autoantibody-induced apoptosis of platelets in immune thrombocytopenia (ITP)	7
Association of inflammation and abnormal lipid metabolism with risk of thrombosis and thrombosis progression in patients with polycythemia vera: a retrospective study	7
Busulfan plus melphalan versus high-dose melphalan as a conditioning regimen for autologous stem cell transplantation in multiple myeloma with high-risk features (KMM 2015)	7
Non-viral pathogens of infectious diarrhoea post-allogeneic stem cell transplantation are associated with graft-versus-host disease	6
Treatment with idelalisib in patients with chronic lymphocytic leukemia – real world data from the registry of the German CLL Study Group	6
Outcome prediction by interim positron emission tomography and IgM monoclonal gammopathy in diffuse large B-cell lymphoma	6
Clinical usefulness of next-generation sequencing-based target gene sequencing in diagnosis of inherited bone marrow failure syndrome	6
Infectious complications in CLL/SLL patients receiving Bruton's Tyrosine Kinase inhibitors – systematic review and meta-analysis of randomized controlled trials	6